Berberine decreased N-acetylation of 2-aminofluorene through inhibition of N-acetyltransferase gene expression in human leukemia HL-60 cells

Anticancer Research

Volumn 25, Issue 6 B, 2005, Pages 4149-4155

  Lin, Chin Chung ^a,c   Kao, Shung Te ^a   Chen, Guang Wei ^a   Chung, Jing Gung ^b  

^a School of Chinese Medicine   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c FENG YUAN HOSPITAL   (Taiwan)

Author keywords

2 aminofluorene (AF); Berberine; Flow cytometry; Leukemia cell line (HL 60); N acetyltransferase (NAT)

Indexed keywords

2 FLUORENYLAMINE; ACYLTRANSFERASE; ACYLTRANSFERASE INHIBITOR; BERBERINE; MESSENGER RNA;

ARTICLE; CELL STRAIN HL 60; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACETYLATION; ENZYME ACTIVITY; ENZYME INHIBITION; FLOW CYTOMETRY; GENE; GENE EXPRESSION REGULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LEUKEMIA CELL; NAT GENE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; STAINING; WESTERN BLOTTING;

ACETYLATION; ARYLAMINE N-ACETYLTRANSFERASE; BERBERINE; BLOTTING, WESTERN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FLOW CYTOMETRY; FLUORENES; GENE EXPRESSION; HL-60 CELLS; HUMANS; ISOENZYMES; LEUKEMIA, PROMYELOCYTIC, ACUTE; POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 27944469465     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Dairou J, Atmane N, Rodrigues-Lima F and Dupret JM: Peroxynitrite irreversibly inactivates the human xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 (NAT1) in human breast cancer cells: a cellular and mechanistic study. J Bio Chem 279: 7708-7714, 2004.
2. Ghosh AK, Bhattacharyya FK and Ghosh DK: Leishmania donovani: amastigote inhibition and mode of action of berberine. Exp Parasitol 60: 404-413, 1985.
3. Wang F, Zhou HY, Zhao G, Fu LY, Cheng L, Chen JG and Yao WX: Inhibitory effects of berberine on ion channels of rat hepatocytes. World J Gastroenterol 10: 2842-2845, 2004.
4. Hahn FE and Ciak J: Antibiotics. In: Gottliele D, Shaw PD and Cocoran JW (eds.). Springer-Verlag Press, Vol. 3, New York, pp. 577, 1975.
5. Ghosh AK, Bhaktachoryya FK and Ghosh DK: Amastigote inhibition and mode of action of berberine. Exp Parasitol 60: 404-413, 1985.
6. Hano K: Pharmacological studies on metabolism of cancer tissues: pharmacological studies on carcinostatic effects of some plant components and their derivatives. Gann 48: 443-450, 1957.
7. Hoshi A, Ikekawa T, Ikeda Y, Shirakawa S, Ligo M, Karetani K and Fukoka F: Antitumor activity of berberine derivatives. Gann 67: 321-325, 1976.
8. Zhang RX: Laboratory studies of berberine used alone and in combination with 1,3-bis(2-chloroethyl)-1-nitrosourea to treat malignant brain tumors. Chinese Med J 103: 658-665, 1990.
9. Li KK, Motwani M, Tong W, Bornmann W and Schwartz GK: Huanglian, a Chinese herbal extract, inhibits cell growth by suppressing the expression of cyclin B1 and inhibiting CDC2 kinase activity in human cancer cells. Mol Pharmacol 55: 1287-1293, 2000.
10. Kuo CL, Chou CC and Yung BYM: Berberine complexes with DNA in berberine-induced apoptosis in human leukemia HL-60 cells. Cancer Lett 93: 193-200, 1995.
11. Butcher NJ, Ilett KF and Minchin RF: Substrate-dependent regulation of human arylamine N-acetyltransferase-1 in cultured cells. Mol Pharmacol 57: 468-473, 2000.
12. Chung JG, Chen GW, Wu LT, Chang HL, Lin JG, Yeh CC and Wang TF: Effects of garlic compounds diallyl sulfide and diallyl disulfide on arylamine N-acetyltransferase activity in strains of Helicobacter pylori from peptic ulcer patients. Am J Chin Med 26: 353-364, 1998.
13. Lang NP, Chu DZJ, Hunter CF, Kendall DC, Flamang TJ and and Kadlubar FF: Role of aromatic amine acetyltransferase in human colorectal cancer. N Arch Surg 121: 1259-1261, 1986.
14. Cartwright RA, Glasham RW, Rogers HJ, Ahmed RA, Barham-Hall D, Higgens E and Kahn MA: Role of N-acetyltransferase phenotype in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet 2: 842-846, 1982.
15. Chung JG, Wu LT, Chu CB, Jan JY, Ho CC, Tsou MF, Lu HF, Chen GW, Lin JG and Wang TF: Effects of berberine on arylamine N-acetyltransferase activity in human bladder tumour cells. Food Chem Toxicol 37: 319-326, 1999.
16. Lin JG, Chung JG, Wu LT, Chen GW, Chang HL and Wang TF: Effects of berberine on arylamine N-acetyltransferase activity in human colon tumor cells. Am J Chin Med 27: 265-275, 1999.
17. Chung JG, Chen GW, Hung CF, Lee JH, Ho CC, Ho HC, Chang HL, Lin WC and Lin JG: Effects of berberine on arylamine N-acetyltransferase activity and 2-aminofluorene-DNA adduct formation in human leukemia cells. Am J Chin Med 28: 227-238, 2000.
18. Wang DY, Yeh CC, Lee JH, Hung CF and Chung JG: Berberine inhibited arylamine N-acetyltransferase activity and gene expression and DNA adduct formation in human malignant astrocytoma (G9T/VGH) and brain glioblastoma multiforme (GBM 8401) cells. Neurochem Res 27: 883-889, 2002.
19. Tan TW, Tsai HY, Chen YF and Chung JG.: Induction of apoptosis in human promyelocytic leukemia HL-60 cells by Ampelopsis cantoniensis crude extract. In Vivo 18: 457-462, 2004.
20. Yang CC, Yang JH, Lu HF, Chen SY, Lin SY and Chung JG: N-acetyltransferase activity is involved in paclitaxel-induced N-acetylation of 2-aminofluorene in human bladder cancer cells (T24). Anticancer Res 24: 1501-1506, 2004.
21. Li YC, Tyan YS, Kuo HM, Chang WC, Hsia TC and Chung JG: Baicalein induced in vitro apoptosis undergo caspases activity in human promyelocytic leukemia HL-60 cells. Food Chem Toxicol 42: 37-43, 2004.
22. Chung JG, Yeh KT, Wu SL, Hsu NY, Chen GW, Yeh YW and Ho HC: Novel transmembrane GTPase of non-small cell lung cancer identified by mRNA differential display. Cancer Res 61: 8873-8879, 2001.
23. Chung JG, Li YC, Lee YM, Lin JP, Cheng KC and Chang WC: Aloe-emodin inhibited N-acetylation and DNA adduct of 2-aminofluorene and arylamine N-acetyltransferase gene expression in mouse leukemia L 1210 cells. Leukemia Res 27: 831-840, 2003
24. Yu CS, Yu FS, Chuang YC, Lu HF, Lin SY, Chiu TH and Chung JG: Wogonin inhibits N-acetyltransferase activity and gene expression in human leukemia HL-60 cells. Anticancer Res 25: 127-132, 2005.
25. Chung JG, Lu HF, Yeh CC, Cheng KC, Lin SS and Lee JH: Inhibition of N-acetyltransferase activity and gene expression in human colon cancer cell lines by diallyl sulfide. Food Chem Toxicol 42: 195-202, 2003.
26. Lu KH, Wang DY, Lue KH, Hsiao YM, Chou MC, Chen YS and Chung JG: PCR and flow cytometric analysis of paclitaxel-inhibited arylamine N-acetyltransferase activity and gene expression in human osteogenic sarcoma cells (U-2 OS). Anticancer Res 24: 83-90, 2004.
27. Grant DM, Blum M, Beer M and Meyer UA: Monomorphic and polymorphic human arylamine N-acetyltransferase: a comparison of liver isozymes and expressed products of two cloned genes. Mol Pharmacol 39: 184-191, 1991.
28. Minchin RF, Reeves PT, Teitel CH, McManus ME, Mojarrabi T, Ilett KF and Kadlubar FF: N-and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferase expressed in COS-1 cells. Biochem Biophys Res Commun 185: 839-844, 1992.
29. Weber WW: The Acetylator Genes and Drug Response, Oxford University Press, New York, pp. 21-55, 1987.
30. Weber WW and Hein DW: N-acetylation pharmacogenetics. Pharmacol Rev 37: 25-99, 1985.
31. Einisto P, Watanabe M, Ishidate M and Nohmi T: Mutagenicity of 30 chemicals in S. typhimurium possessing different nitroreductase or O-acetyltransferase activities. Mutation Res 259: 95-102, 1991.
32. Smith G, Stanley LA, Sim E, Strange RC and Wolf CR: Metabolic polymorphisms and cancer susceptibility. Cancer Surv 25: 27-65, 1995.
33. Thorgeirsson SS, Glowinski IB and McManus ME: Metabolism, mutagenicity carcinogenicity of aromatic amines. In: Hodgson J, Bend J and Philpot RM (eds.), Reviews in Biochemical Toxicity, Vol. 6, Elsevier/North Holland Biomedical Press, New York, pp. 349-386, 1983.
34. Hayes MA, Roberts E, Safe SH, Farber E and Cameron RG: Influences of different polychlorinated biphenyls on cytocidal mitoinhibitory and nodule-selecting activities of N-2-fluorenylacetamide in rat liver. JNCI 76: 683-690, 1986.
35. Ikezawa N, Tanaka M, Nagayoshi M, Shinkyo R, Sakaki T, Inouye K and Sato F: Molecular cloning and characterization of CYP719: a methylenedioxy bridge-forming enzyme that belongs to a novel P450 family, from cultured Coptis japonica cells. J Biol Chem 278: 38557-38565, 2003.
36. Sono M, Roach MP, Coulter ED and Dawson JH: Heme-containing oxygenases. Chem Rev 96: 2841-2842, 1996.